• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Isabella Rater

Latest:

A Multistakeholder Effort in Pennsylvania to Improve the Accuracy of Reporting Fatal Drug Overdoses

The authors describe a novel training program for death certifiers in Pennsylvania, which has been designed to specifically focus on some of the main challenges in the death certification process and resulted in a useful model that can potentially be adopted by other states or municipalities.


Erin Crown, MHS, PA-C, Psych-CAQ

Latest:

Patient Experience with PDTs

Panelists discuss how patients express satisfaction with digital therapeutics for their convenience and real-time accessibility, though lack of payer coverage limits the ability to gather meaningful real-world evidence on their effectiveness.


Anthony Park, BS

Latest:

Long-Term Health Care Costs Following COVID-19: Implications for Pandemic Preparedness

A difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.


Susan Escudier, MD

Latest:

Cancer Care Strategies Addressing Social Determinants of Health: Susan Escudier, MD

Susan Escudier, MD, FACP, of Texas Oncology, suggests actionable insights to improve equitable access to patient cancer care


Trudy M. Krause, DrPH

Latest:

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.


Kim Perry | Image Credit: emtelligent
Kim Perry

Latest:

Contributor: Unlocking the Value of Unstructured Data From Continuity of Care Documents Using Medical-Grade NLP

Clinical-grade, expert-supported natural language processing (NLP) is valuable to payers and providers when exchanging patient information through continuity-of-care documents.



Melissa Feeney, PhD

Latest:

Value-Based Care Interventions and Management of CKD Progression

Patients with chronic kidney disease (CKD) stages 3b or 4 experienced slower decline in estimated glomerular filtration rate 20 months after enrollment in a value-based kidney care program.


Lisa R. Shugarman, PhD

Latest:

Regulation of Provider Networks in Response to COVID-19

The authors describe federal and state provider network adequacy standards and discuss how regulators should adapt these standards and accompanying monitoring processes in response to coronavirus disease 2019 (COVID-19).


Andrew Evens, DO | image credit: cinj.org
Andrew Evens, DO

Latest:

Evaluating A-HIPI vs Traditional Scores in Advanced Hodgkin Lymphoma: Andrew Evens, DO, MBA, MSc

Andrew Evens, DO, MBA, MSc, shares insights from a study on improving prognostic accuracy for advanced-stage Hodgkin lymphoma.


Adesuwa Olomu, MD, MS

Latest:

Type 2 Diabetes Patient Activation and mHealth Interventions Decreased Cardiovascular Disease Risk

Mobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.


Hadar Lev-Tov, MD

Latest:

Follow-Up and Monitoring: Proactive Strategies for Long-Term Patient Engagement After Hidradenitis Suppurativa Diagnosis

Panelists discuss the critical role of effective follow-up and multidisciplinary care in managing hidradenitis suppurativa, emphasizing ongoing patient education, coordinated referrals, and personalized treatment plans to improve adherence and long-term outcomes.


Brooke Adams, PharmD, BCOP

Latest:

Safety Considerations and Practical Strategies for Using Bispecific Antibodies in Multiple Myeloma

Explore the safety considerations and unique toxicities of bispecific antibodies, including cytokine release syndrome and neurotoxicity management.


Ibrahim Aldoss, MD

Latest:

Early SYRUS Data Highlight Safety, Efficacy of AZD0486 in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD

AZD0486 demonstrated encouraging safety and dose-dependent efficacy in heavily pretreated adolescent and adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL), according to early findings from the phase 1/2 SYRUS trial and Ibrahim Aldoss, MD, of City of Hope.


Ajay Anand, PhD

Latest:

Availability of Prices for Shoppable Services on Hospital Internet Sites

Only 60% of hospitals display their cash prices and 5% display their minimum negotiated charges on their public websites; many hospitals are in violation of new federal legislation.


Kenna R. Mills Shaw, PhD

Latest:

Comprehensive Genomic Profiling in Community Oncology

Recommendations to address limitations in more widespread use of reflex testing in community oncology.



Shannon Lynch, FNP

Latest:

Telehealth User Experiences During COVID-19: A Case Study of Outpatient Cardiovascular Clinics Affiliated With a Large Academic Practice

In cardiovascular clinics during COVID-19, notable barriers to successful telehealth use included obtaining diagnostic information needed to deliver high-quality care and technology-related challenges for patients.


Azazaiah Israel, BSc

Latest:

Type 2 Diabetes Patient Activation and mHealth Interventions Decreased Cardiovascular Disease Risk

Mobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.


Balazs Halmos, MD

Latest:

Subcutaneous Amivantamab for NSCLC Could Benefit Patients, Practices: Balazs Halmos, MD

Balazs Halmos, MD, of Montefiore Albert Einstein Cancer Center, discussed the potential impact of subcutaneous amivantamab EGFR-mutated NSCLC.



Q Burkhart, MS

Latest:

Sex Differences in Medicare Beneficiaries’ Experiences by Low-Income Status

Only low-income male Medicare beneficiaries had worse patient experience than their female counterparts. The authors discuss opportunities to improve experiences for all patients.


Jill W. Ruppenkamp, MSc

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


Jason Shriver, OT

Latest:

Impact of Functional Recovery on Patients Having Heart Surgery

This article describes the positive impact that actively managing functional recovery has on postacute placement for patients undergoing coronary artery bypass surgery.


Andy Bogart, MS

Latest:

Do Localized Disasters Impact Clinical Measures of Health Care Quality?

This study examines the impact of geographically limited disasters on health care quality performance scores of Medicare Advantage contracts, finding limited impact on performance scores.


Franco Nicolae Grados Rodriguez

Latest:

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Because evidence gaps in idiopathic pulmonary fibrosis research hinder demonstration of antifibrotic therapies’ impact on patient quality of life (QOL), integrating validated health-related QOL measures into trials is urgently needed.


Harold A. Pollack, PhD

Latest:

Preventing Tomorrow’s High-Cost Claims: The Rising-Risk Patient Opportunity in Medicaid

For Medicaid care management, focusing on rising-risk patients is more effective than targeting high-cost claimants, whose spending tends to decrease over time due to regression to the mean.


John Cerda, BA

Latest:

Implementing Clinical Informatics Tools for Primary Care–Based Diabetic Retinopathy Screening

The authors describe a primary care–based diabetic retinopathy screening program incorporating telemedicine, strong health information technology engagement, and development of clinical informatics tools.


Lisa M. Nyberg, MD, MPH

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


Joshua Fitch

Latest:

Maternal and Infant RSV Immunization Safe, Effective Regardless of Sequence

Combined or individual use of maternal RSVpreF and infant nirsevimab achieved high antibody levels without safety concerns, supporting current RSV prevention strategies.

© 2026 MJH Life Sciences
AJMC®
All rights reserved.